Agencia Comercial Spirits vs Cellyan Biotechnology
AGCC and HKPD side by side, both in wholesale trade-non-durable goods. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AGCC and HKPD compare
Agencia Comercial Spirits grew revenue faster over the last twelve months (145% versus −33.9% for Cellyan Biotechnology).
Agencia Comercial Spirits keeps more of each dollar of sales as profit, with a net margin of 9.8% compared with −8.5% at Cellyan Biotechnology.
Agencia Comercial Spirits scores higher on the StockData Score (6 against 3 for Cellyan Biotechnology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AGCC | HKPD |
|---|---|---|
| Size and price | ||
| Share price | $14.15 | $1.62 |
| Change, 1 year | 155% | −93.4% |
| Beta (5Y) | 1.50 | – |
| Employees | 23 | 2 |
| StockData Score | ||
| Total score | 6 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 3 (better) | 1 |
| Health score | 2 | 2 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 145% (better) | −33.9% |
| Net income growth (TTM) | −21.8% | – |
| EPS growth (TTM) | −38.5% | – |
| Profitability | ||
| Gross margin | 30.4% (better) | 10.3% |
| Operating margin | 12.6% (better) | −17.8% |
| Net margin | 9.8% (better) | −8.5% |
| FCF margin | – | −5.9% |
| Return on equity | 10.4% (better) | −15.5% |
| Return on invested capital | 14.4% (better) | −22.5% |
| Financial health | ||
| Debt / equity | 1.27 | 0.09 (better) |
| Net debt / EBITDA | −4.26 | – |
| Interest coverage | 363× (better) | −17.8× |
| Current ratio | 1.53 | 3.86 (better) |
| Piotroski F-score | 3 | 3 |
| Ownership | ||
| Held by institutions | 0.11% | 1.5% |
| Held by insiders | 84.4% | 81.9% |
| Short interest, % of float | 0.64% | 0.57% |
Go deeper
- AGCC stock overview
- AGCC income statement
- AGCC valuation and score
- HKPD stock overview
- HKPD income statement
- HKPD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.